<DOC>
	<DOCNO>NCT01435577</DOCNO>
	<brief_summary>The purpose trial establish safety efficacy multiple dose treatment tapentadol IV adult population moderate severe pain follow bunionectomy .</brief_summary>
	<brief_title>Intravenous Tapentadol Post-Bunionectomy Pain</brief_title>
	<detailed_description />
	<criteria>Scheduled undergo primary unilateral first metatarsal bunionectomy Female patient must postmenopausal , surgically sterile , practice effective method birth control sexually active Qualifying pain intensity ( within maximum 5 hour last surgical stitch ) Baseline pain intensity ( last pain score measure within 10 minute dose ) 5 11point ( 0 10 ) pain intensity numerical rating scale ( NRS ) . History malignancy within past 2 year Current history alcohol drug abuse . Clinically relevant pulmonary , gastrointestinal , endocrine , metabolic , neurological , psychiatric disorder ( result disorientation , memory impairment inability report accurately History seizure disorder , epilepsy , condition would put subject risk seizure Severely impaired renal function Moderately severely impair hepatic function Contraindications , history allergy hypersensitivity , tapentadol , ibuprofen , excipients Use prohibit concomitant medication , allow use restrict concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Bunionectomy</keyword>
	<keyword>Postsurgical Pain</keyword>
	<keyword>Acute Pain</keyword>
</DOC>